The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate cancer in 2010, and another was approved in 2015 for melanoma. Since then, ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...

ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an "alternative source ...

Issued on behalf of Oncolytics Biotech Inc. "We're hitting critical milestones that validate our progress and set the stage for what we believe will be an exciting year," said Wayne Pisano, Interim ...

CDC holds that vaccines are a safe, effective way to protect your health and prevent the spread of flu, COVID, measles. What ...

Predictive Oncology (POAI) provided an update highlighting new successes with its drug repurposing initiative. Using publicly available ...

This summary covers recent health news, including Wyoming's first human H5N1 bird flu case, WHO's call for cancer warning ...

The latest health briefs discuss the halt of Moderna’s norovirus vaccine trial, health policy changes under Robert F. Kennedy ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...